| The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape L Lyu, Y Feng, X Chen, Y Hu Nature biotechnology 38 (12), 1387-1394, 2020 | 28 | 2020 |
| A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza-Ligusticum chuanxiong as an example DY Zhang, RQ Peng, X Wang, HL Zuo, LY Lyu, FQ Yang, YJ Hu Journal of ethnopharmacology 292, 115197, 2022 | 20 | 2022 |
| A review of cutting-edge therapies for hepatocellular carcinoma (HCC): perspectives from patents Y Gao, L Lyu, Y Feng, F Li, Y Hu International journal of medical sciences 18 (14), 3066, 2021 | 14 | 2021 |
| A target map of clinical combination therapies in oncology: an analysis of clinicaltrials. gov J Yang, H Kang, L Lyu, W Xiong, Y Hu Discover Oncology 14 (1), 151, 2023 | 11 | 2023 |
| The internationalization of TCM towards Portuguese-speaking countries X Zheng, L Lyu, H Lu, Y Hu, G Chan Chinese Medicine 16 (1), 81, 2021 | 10 | 2021 |
| The financial impact of patents on SMEs in China: Empirical evidence from pharmaceutical sector Y Feng, K Liu, L Lyu, G Sun, Y Hu Science, Technology and Society 27 (1), 46-65, 2022 | 6 | 2022 |
| Expanding potential targets of herbal chemicals by node2vec based on herb–drug interactions D Zhang, W Cui, L Hou, J Yang, L Lyu, Z Wang, KG Linghu, W He, H Yu, ... Chinese Medicine 18 (1), 64, 2023 | 4 | 2023 |
| Mapping the global landscape for induced pluripotent stem cells from patents and clinical trials L Lyu, Y Feng, B Huang, RH Xu, Y Hu Nature Biotechnology 42 (4), 563-569, 2024 | 3 | 2024 |
| Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials D Zhang, L Lyu, S Han, J Xu, G Hu, Q Zhao, Y Hu International Immunopharmacology 126, 111273, 2024 | | 2024 |
